Detalles de la búsqueda
1.
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial.
Immunology
; 167(3): 340-353, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35758850
2.
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
BMC Cancer
; 22(1): 960, 2022 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071409
3.
Evaluating the safety and effectiveness of PegaGen® (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study.
Support Care Cancer
; 30(10): 8151-8158, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35792924
4.
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of Alvotereâ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy.
Curr Ther Res Clin Exp
; 96: 100659, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35035631
5.
Post-Marketing Surveillance of a generic Oxaliplatin (Alvoxalâ) in Iranian Patients with Cancer.
Curr Ther Res Clin Exp
; 96: 100657, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35024073
6.
Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
BMC Cancer
; 22(1): 1348, 2022 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550442
7.
Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial.
Int Immunopharmacol
; 127: 111436, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38147778
8.
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial.
Clin Microbiol Infect
; 29(2): 215-220, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096430
9.
Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study.
Arch Iran Med
; 26(11): 647-653, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310425
10.
Efficacy of Biosimilar Adalimumab in the Treatment of Behçet's Uveitis.
Ocul Immunol Inflamm
; 30(6): 1495-1500, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826486
11.
Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical Trial.
Clin Ther
; 44(12): 1566-1576, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402595
12.
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.
Clin Microbiol Infect
; 28(9): 1263-1271, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35436611
13.
Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial.
Arthritis Res Ther
; 24(1): 161, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773713
14.
Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis.
Expert Rev Clin Immunol
; 17(5): 499-511, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823733
15.
Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study.
Caspian J Intern Med
; 12(Suppl 2): S491-S494, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34760113
16.
A Phase IV Study of the Safety and Efficacy of CinnoPar® in Iranian Patients with Osteoporosis.
J Osteoporos
; 2021: 7584308, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34194720
17.
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar.
Front Neurol
; 12: 682622, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34512504
18.
Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study.
Adv Ther
; 38(2): 1290-1300, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33432540
19.
A randomized phase I pharmacokinetic trial comparing the potential biosimilar adalimumab (CinnoRA®) with the reference product (Humira®) in healthy volunteers.
Expert Opin Investig Drugs
; 29(3): 327-331, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31985294
20.
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial.
Int Immunopharmacol
; 89(Pt B): 107102, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33075713